Table: begin end state 1 22 cytoplasmic 23 42 transmembrane 43 60 non-cytoplasmic 61 79 transmembrane 80 90 cytoplasmic 91 111 transmembrane 112 116 non-cytoplasmic 117 141 transmembrane 142 153 cytoplasmic 154 175 transmembrane 176 201 non-cytoplasmic 202 224 transmembrane 225 248 cytoplasmic 249 272 transmembrane 273 287 non-cytoplasmic 288 307 transmembrane 308 316 cytoplasmic 317 336 transmembrane 337 341 non-cytoplasmic 342 364 transmembrane 365 375 cytoplasmic 376 394 transmembrane 395 399 non-cytoplasmic 400 420 transmembrane 421 435 cytoplasmic
Input: >WP_066605879.1 NCBI__GCF_001046645.1:WP_066605879.1 MAGPISSGAGVTATHNPGTRYGPALALLASLFFMWGFITVINNTLLPHLRSVFELSYTQT TLIESVWFIAYFVASIPSAKLIERVGYQKSLVIGLLIMAAGALGMTVAASIPSYGVTLVM LFVIASGITLLQVAANPYVAIVGKPETASSRLNLVQAMNSAGTMLAPLFGAYLILGRSKG GTAQGDVVLTQAERLADAQSVILPYVIVAVVLAVLAIVIARFPLPAMGNATQRHNKEERK KHSLWNHRNLVFGIPAIFIYLIAEIGVANLFVNFVSQPDIANLTHEQAGRYLTFLWGGMM IGRFAGSAIMQKFDAGHVLAAFSIGAFIVMLVTVFTTGPVAMWSLILVGLFHSIMFPTIF TLGIKGLGPLTEEGSGLLIMAIAGGALVVVQGWLADHYGLQTSFLLTAICELYILFYALW GSKTTNALPDQQVEA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server